TY - JOUR
T1 - Biosynthetic products from a nearshore-derived gram-negative bacterium enable reassessment of the kailuin depsipeptides
AU - Theodore, Christine M
AU - Lorig-Roach, Nicholas
AU - Still, Patrick C.
AU - Johnson, Tyler A.
AU - Drašković, Marija
AU - Schwochert, Joshua A.
AU - Naphen, Cassandra N.
AU - Crews, Mitchell S.
AU - Barker, Simone A.
AU - Valeriote, Frederick A.
AU - Lokey, R. Scott
AU - Crews, Phillip
N1 - Publisher Copyright:
© 2015 The American Chemical Society and American Society of Pharmacognosy.
PY - 2015/2/20
Y1 - 2015/2/20
N2 - Sampling of California nearshore sediments resulted in the isolation of a Gram-negative bacterium, Photobacterium halotolerans, capable of producing unusual biosynthetic products. Liquid culture in artificial seawater-based media provided cyclic depsipeptides including four known compounds, kailuins B-E (2-5), and two new analogues, kailuins G and H (7 and 8). The structures of the new and known compounds were confirmed through extensive spectroscopic and Marfey's analyses. During the course of these studies, a correction was made to the previously reported double-bond geometry of kailuin D (4). Additionally, through the application of a combination of derivatization with Mosher's reagent and extensive (13)C NMR shift analysis, the previously unassigned chiral center at position C-3 of the β-acyloxy group of all compounds was determined. To evaluate bioactivity and structure-activity relationships, the kailuin core (13) and kailuin lactam (14) were prepared by chiral synthesis using an Fmoc solid-phase peptide strategy followed by solution-phase cyclization. All isolated compounds and synthetic cores were assayed for solid tumor cell cytotoxicity and showed only minimal activity, contrary to other published reports. Additional phenotypic screenings were done on 4 and 5, with little evidence of activity.
AB - Sampling of California nearshore sediments resulted in the isolation of a Gram-negative bacterium, Photobacterium halotolerans, capable of producing unusual biosynthetic products. Liquid culture in artificial seawater-based media provided cyclic depsipeptides including four known compounds, kailuins B-E (2-5), and two new analogues, kailuins G and H (7 and 8). The structures of the new and known compounds were confirmed through extensive spectroscopic and Marfey's analyses. During the course of these studies, a correction was made to the previously reported double-bond geometry of kailuin D (4). Additionally, through the application of a combination of derivatization with Mosher's reagent and extensive (13)C NMR shift analysis, the previously unassigned chiral center at position C-3 of the β-acyloxy group of all compounds was determined. To evaluate bioactivity and structure-activity relationships, the kailuin core (13) and kailuin lactam (14) were prepared by chiral synthesis using an Fmoc solid-phase peptide strategy followed by solution-phase cyclization. All isolated compounds and synthetic cores were assayed for solid tumor cell cytotoxicity and showed only minimal activity, contrary to other published reports. Additional phenotypic screenings were done on 4 and 5, with little evidence of activity.
KW - Biological Factors
KW - Depsipeptides
KW - Gram-Negative Bacteria
KW - Humans
KW - Molecular Structure
KW - Nuclear Magnetic Resonance
KW - Biomolecular
KW - Photobacterium
KW - Structure-Activity Relationship
UR - https://scholar.dominican.edu/natural-sciences-and-mathematics-faculty-scholarship/3
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699550/pdf/nihms740641.pdf
U2 - 10.1021/np500840n
DO - 10.1021/np500840n
M3 - Article
C2 - 25699470
VL - 78
SP - 441
EP - 452
JO - Journal of Natural Products
JF - Journal of Natural Products
IS - 3
ER -